MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹1,019 Cr | ₹89 Cr | ₹48 Cr | ₹83 Cr | ₹35 Cr |
What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹1,019 Cr |
Mar2024 | ₹89 Cr |
Mar2023 | ₹48 Cr |
Mar2022 | ₹83 Cr |
Mar2021 | ₹35 Cr |
How is Contingent Liabilities of MANKIND PHARMA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹1,019 Cr | 1,045.33 | |
Mar2024 | ₹89 Cr | 85.77 | |
Mar2023 | ₹48 Cr | -41.97 | |
Mar2022 | ₹83 Cr | 137.32 | |
Mar2021 | ₹35 Cr | - |
Compare Contingent Liabilities of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹107,551.7 Cr | 5.5% | 0.2% | 14% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,187.0 Cr | 0.6% | -2.4% | -7% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,282.0 Cr | -0.3% | -7.6% | 23% | Stock Analytics | |
CIPLA | ₹128,619.0 Cr | 1.8% | 8.1% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,712.0 Cr | 0.9% | 3.7% | 8.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,577.0 Cr | 1% | 2.4% | -9.6% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 5.5% |
0.2% |
14% |
SENSEX | 0.9% |
-1.1% |
0.6% |
You may also like the below Video Courses